HDAC11 and cancer: Given HDAC11’s prominent roles in neural, immune, and metabolic regulation—and its implication in a wide range of diseases including cancer, neurodegeneration, and inflammatory disorders—there is growing interest in targeting this enzyme pharmacologically.